Understanding The Business Model Of Gene Therapy Companies – Peeling The Onion Back To Understand Why Time Matters

By Deanna Petersen and Holly May, Chief Business Officer and Chief Commercial Officer, respectively, of AVROBIO, as part of the From The Trenches feature of LifeSciVC

Moving from traditional drug development and commercialization to gene therapy development and commercialization can be compared to moving from horses to cars as modes of transportation. That’s the analogy our CSO, Chris Mason, uses to describe the difference. Horses and cars were both game changers for transport in their respective eras (and cars continue to be), but both required different strategies to thrive.

Instead of building barns and growing hay and oats for horses,…